SANTA FE SPRINGS, Calif.--(BUSINESS WIRE)--Applied BioCode, Inc. and EraGen Biosciences Inc. today announced that they have entered into a strategic partnership and license agreement. The agreement provides EraGen with access to Applied BioCode's Barcoded Magnetic Bead technology and the CE-marked BioCode-1000 system. The technology provides a robust and reliable solution for development and clinical laboratory use of multiplexed infectious disease and genetic tests.
"We are very pleased to partner with EraGen in such an important and valuable segment of the molecular diagnostics market. The combination of EraGen's patented chemistry with our Barcoded Magnetic Beads and BioCode-1000 system will provide a powerful testing platform for clinical laboratories," said Winston Ho, Ph.D., president of Applied BioCode. "Our strategic partnership and license agreement with EraGen in an important part of our efforts to commercialize the Barcoded Magnetic Bead product globally."
"The versatility of EraGen's DNA and RNA detection chemistry is a cornerstone of our efforts to continually better serve our clinical laboratory customers," said Irene Hrusovsky, M.D., chairman and chief executive of EraGen. "We look forward to commercializing molecular diagnostics that address not only customers needing real-time molecular testing, but also those in the growing segment that need highly-multiplexed in vitro diagnostics. Our relationship with Applied BioCode will help us reach those goals."
Additional terms of the strategic partnership and license agreement were not disclosed.
About Applied BioCode, Inc.
Applied BioCode is a privately-held biotechnology company with headquarters in Santa Fe Springs, California. Applied BioCode develops, manufactures, and markets highly-multiplexed products to customers focused on molecular diagnostics, bioresearch, and biomarker validation. Applied BioCode maintains an extensive collaborative network with universities, government laboratories, and industrial partners. Several of Applied BioCode’s partners have adapted their molecular diagnostic assays to the Barcoded Magnetic Bead format. This approach enables the company to optimize efficiency and resources, and leverage those optimizations to help its customers maximize the benefit of its powerful tools and collaborative networks. For more information, please visit the Applied BioCode's website at www.ApBioCode.com.
About EraGen Biosciences Inc.
EraGen Biosciences develops, manufactures, and markets molecular reagent products that are driving a new era in clinical diagnostics. The company's in-market and pipeline products, based on its novel, patented MultiCode® platform chemistry, are the next generation of DNA- and RNA-based testing for the early detection of infectious diseases and genetic-based conditions. EraGen's expanding menu of high quality, easy-to-use products position the company for leadership in the molecular diagnostics market. For more information, please visit the EraGen website at www.eragen.com.
